Suppr超能文献

米索前列醇用于终止妊娠时感染与发热之间的关联:一项回顾性队列研究。

Association between infection and fever in terminations of pregnancy using misoprostol: a retrospective cohort study.

作者信息

Nijman Tobias A J, Voogdt Kevin G J A, Teunissen Pim W, van der Voorn Patrick J Jp, de Groot Christianne J M, Bakker Petra C A M

机构信息

Department Obstetrics and Gynecology, Division Woman & Baby, UMC, Lundlaan 6, 3508 AB, Utrecht, The Netherlands.

Department Obstetrics and Gynecology, VUmc, Amsterdam, The Netherlands.

出版信息

BMC Pregnancy Childbirth. 2017 Jan 5;17(1):7. doi: 10.1186/s12884-016-1188-1.

Abstract

BACKGROUND

Fever is a well-known side effect of misoprostol, but clinically difficult to distinguish from an intra uterine infection. The aim of this study was to determine the incidence of fever in terminations of pregnancy (TOP) using misoprostol and to evaluate fever as indication of intra uterine infection.

METHODS

A retrospective cohort study was performed. Consecutive second trimester TOP with misoprostol between January 2008 and October 2012 were selected. We included 403 cases and determined the incidence of fever. To examine intra uterine infection as plausible cause of fever, pathological examination reports of placentas were reviewed for signs of infections.

RESULTS

The incidence of fever was 42%. Logistic regression showed a dose dependent association between dosage misoprostol and degree of fever (OR 1.86; 95% CI: 1.3-2.7). There was no association between fever and epidural analgesia. Fever has a sensitivity of 55% and a specificity of 58% as a marker of intra uterine infection. The positive predictive value of fever for an intra uterine infection is 4% and the negative predictive value is 98%.

CONCLUSION

Administration of misoprostol for the indication TOP is strongly associated with fever during labor. Fever is a poor predictor of intra uterine infection in the context of TOP.

摘要

背景

发热是米索前列醇已知的副作用,但临床上难以与宫内感染相区分。本研究的目的是确定使用米索前列醇进行妊娠终止(TOP)时发热的发生率,并评估发热作为宫内感染指标的情况。

方法

进行了一项回顾性队列研究。选取2008年1月至2012年10月间连续使用米索前列醇进行中期妊娠终止的病例。我们纳入了403例病例并确定了发热的发生率。为检查发热可能的原因——宫内感染,对胎盘的病理检查报告进行了审查以寻找感染迹象。

结果

发热发生率为42%。逻辑回归显示米索前列醇剂量与发热程度之间存在剂量依赖性关联(比值比1.86;95%置信区间:1.3 - 2.7)。发热与硬膜外镇痛之间无关联。发热作为宫内感染标志物的敏感性为55%,特异性为58%。发热对宫内感染的阳性预测值为4%,阴性预测值为98%。

结论

用于妊娠终止指征的米索前列醇给药与分娩期间发热密切相关。在妊娠终止的情况下,发热是宫内感染的不良预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ed2/5217304/8e3775dee2a2/12884_2016_1188_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验